Arcadia Biosciences (RKDA) Other Non-Current Liabilities (2014 - 2025)

Arcadia Biosciences' Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $1.0 million for Q1 2025.

• Quarterly Other Non-Current Liabilities fell 50.0% year-over-year to $1.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.0 million (down 50.0% YoY) and the FY2024 annual result came in at $2.0 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities was $1.0 million for Q1 2025 at Arcadia Biosciences, down from $2.0 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $2.1 million in Q1 2021 and bottomed at $1.0 million in Q1 2025.
• A 5-year average of $2.0 million and a median of $2.0 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Other Non-Current Liabilities advanced 7.0% — and 2025, when it plunged 50.0%.
• Arcadia Biosciences' Other Non-Current Liabilities stood at $2.1 million in 2021, then decreased by 3.38% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then plunged by 50.0% to $1.0 million in 2025.
• Business Quant data shows RKDA's Other Non-Current Liabilities at $1.0 million in Q1 2025, $2.0 million in Q4 2024, and $2.0 million in Q3 2024.